# Cellular Biomedicine Group, Inc. (CBMG)

Source: https://www.quantisnow.com/company/CBMG
Generated: 2026-11-19T01:09:39.905Z

- Ticker: CBMG
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year: n/a

## Latest CBMG news and filings

- 2021-03-03 19:40 UTC [SEC Form 15-12G filed](https://www.quantisnow.com/insight/sec-form-15-12g-filed-466999)
- 2021-02-26 05:15 UTC [SEC Form EFFECT filed](https://www.quantisnow.com/insight/sec-form-effect-filed-444249)
- 2021-02-26 05:15 UTC [SEC Form EFFECT filed](https://www.quantisnow.com/insight/sec-form-effect-filed-444228)
- 2021-02-26 05:15 UTC [SEC Form EFFECT filed](https://www.quantisnow.com/insight/sec-form-effect-filed-444196)
- 2021-02-26 05:15 UTC [SEC Form EFFECT filed](https://www.quantisnow.com/insight/sec-form-effect-filed-444190)
- 2021-02-19 19:55 UTC [Cellular Biomedicine Group, Inc. Announces Completion of Merger](https://www.quantisnow.com/insight/cellular-biomedicine-group-inc-announces-completion-of-merger-438538)
- 2021-02-20 00:50 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-416852)
- 2021-02-19 21:10 UTC [SEC Form 25-NSE filed](https://www.quantisnow.com/insight/sec-form-25-nse-filed-414998)
- 2021-02-19 20:44 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-414823)
- 2021-02-19 20:13 UTC [SEC Form 4] [SEC Form 4 filed by Jacky Gang Ji](https://www.quantisnow.com/insight/sec-form-4-filed-by-jacky-gang-ji-414726)
- 2021-02-19 20:13 UTC [SEC Form 4] [SEC Form 4 filed by Alan Kwok Chun Au](https://www.quantisnow.com/insight/sec-form-4-filed-by-alan-kwok-chun-au-414725)
- 2021-02-19 20:12 UTC [SEC Form 4] [SEC Form 4: Yihong Yao disposed to the issuer $0 worth of Common Stock (18,900 units at $0.00) and was granted 54,000 units of Common Stock, decreasing ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-yihong-yao-disposed-to-the-issuer-0-414723)
- 2021-02-19 20:13 UTC [SEC Form 4] [SEC Form 4: Tao Wen Liu disposed to the issuer $0 worth of Common Stock (213,076 units at $0.00), decreasing ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-tao-wen-liu-disposed-to-the-issuer-414722)
- 2021-02-19 20:13 UTC [SEC Form 4] [SEC Form 4 filed by Hansheng Zhou](https://www.quantisnow.com/insight/sec-form-4-filed-by-hansheng-zhou-414721)
- 2021-02-19 20:13 UTC [SEC Form 4] [SEC Form 4 filed by Terry Belmont](https://www.quantisnow.com/insight/sec-form-4-filed-by-terry-belmont-414720)
- 2021-02-19 20:13 UTC [SEC Form 4] [SEC Form 4 filed by T Edward Schafer](https://www.quantisnow.com/insight/sec-form-4-filed-by-t-edward-schafer-414719)
- 2021-02-19 20:12 UTC [SEC Form 4] [SEC Form 4: Tony Liu was granted 240,000 units of Common Stock and disposed to the issuer $0 worth of Common Stock (10,700 units at $0.00), decreasing ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-tony-liu-was-granted-240000-units-of-414716)
- 2021-02-19 20:12 UTC [SEC Form 4] [SEC Form 4: K Andrew Chan was granted 48,000 units of Common Stock and disposed to the issuer $0 worth of Common Stock (239,747 units at $0.00), decreasing ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-k-andrew-chan-was-granted-48000-units-414715)
- 2021-02-19 20:10 UTC [SEC Form S-8 POS filed](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-414702)
- 2021-02-19 20:09 UTC [SEC Form POS AM filed](https://www.quantisnow.com/insight/sec-form-pos-am-filed-414700)
- 2021-02-19 20:09 UTC [SEC Form POS AM filed](https://www.quantisnow.com/insight/sec-form-pos-am-filed-414696)
- 2021-02-19 20:07 UTC [SEC Form POS AM filed](https://www.quantisnow.com/insight/sec-form-pos-am-filed-414689)
- 2021-02-19 20:07 UTC [SEC Form POS AM filed](https://www.quantisnow.com/insight/sec-form-pos-am-filed-414684)
- 2021-02-19 20:06 UTC [SEC Form SC 13E3/A filed](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-414681)
- 2021-02-19 20:04 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-414670)
- 2021-02-08 21:32 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-364640)
- 2021-02-01 19:49 UTC [SEC Form DEF 14A filed](https://www.quantisnow.com/insight/sec-form-def-14a-filed-336373)
- 2021-02-01 13:30 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-334400)
- 2021-01-28 21:56 UTC [SEC Form DEFA14A filed](https://www.quantisnow.com/insight/sec-form-defa14a-filed-327187)
- 2021-01-28 21:30 UTC [Leading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine Group Stockholders Vote FOR Proposed Merger](https://www.quantisnow.com/insight/leading-proxy-advisory-firms-glass-lewis-and-iss-recommend-cellular-326950)
- 2021-01-26 22:20 UTC [SEC Form DEFA14A filed](https://www.quantisnow.com/insight/sec-form-defa14a-filed-317789)
- 2020-12-29 21:20 UTC [SEC Form S filed](https://www.quantisnow.com/insight/sec-form-s-filed-243296)
- 2020-12-29 21:11 UTC [SEC Form D filed](https://www.quantisnow.com/insight/sec-form-d-filed-243237)
- 2020-12-04 12:35 UTC [Cellular Biomedicine Group Announces Data to be Presented at 2020 ASH Annual Meeting](https://www.quantisnow.com/insight/cellular-biomedicine-group-announces-data-to-be-presented-at-2020-198228)
- 2020-11-12 17:25 UTC [Moore Kuehn Encourages CGIX, CXO, CBMG, and RESI Investors to Contact Law Firm](https://www.quantisnow.com/insight/moore-kuehn-encourages-cgix-cxo-cbmg-and-resi-investors-to-154919)
- 2020-11-09 21:24 UTC [Cellular Biomedicine Group Reports Q3 2020 Financial Results and Business Highlights](https://www.quantisnow.com/insight/cellular-biomedicine-group-reports-q3-2020-financial-results-and-business-146667)
- 2020-11-07 02:20 UTC [WeissLaw LLP Reminds CCR, CBMG, and MVC Shareholders About Its Ongoing Investigations](https://www.quantisnow.com/insight/weisslaw-llp-reminds-ccr-cbmg-and-mvc-shareholders-about-its-143624)
- 2020-11-06 14:45 UTC [ALERT: Halper Sadeh LLP Investigates the Following Mergers; Investors are Encouraged to Contact the Firm – GLIBA, CBMG, VRTU, MOBL](https://www.quantisnow.com/insight/alert-halper-sadeh-llp-investigates-the-following-mergers-investors-are-142948)
- 2020-11-06 12:01 UTC [Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc., BMC Stock Holdings, Inc., Callaway Golf Company, Cellular Biomedicine Group, Inc., CIT Group Inc., Eidos Therapeutics, Inc., Watford Holdings Ltd. and Yintech Investment Holdings Limited](https://www.quantisnow.com/insight/lifshitz-law-firm-pc-announces-investigation-of-american-renal-associates-142710)
- 2020-11-01 00:50 UTC [ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm - VRTU, AMAG, EV, CBMG](https://www.quantisnow.com/insight/alert-halper-sadeh-llp-reminds-shareholders-about-its-ongoing-merger-131220)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CBMG
- Earnings history: https://www.quantisnow.com/earnings/CBMG
- Dividend history: https://www.quantisnow.com/dividends/CBMG
- Insider transactions: https://www.quantisnow.com/insiders/CBMG
- Options chain: https://www.quantisnow.com/options/CBMG
- SEC 8-K filings only: https://www.quantisnow.com/company/CBMG/8-k
- RSS and alerts for CBMG: https://www.quantisnow.com/docs/rss-feeds.md
